{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:40:49Z","timestamp":1779928849148,"version":"3.53.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The study aimed to evaluate the changes in retinal vascular density in exudative age-related macular degeneration (AMD) after long-term anti-VEGF treatment using optical coherence tomography angiography (OCT-A), and to compare these changes with the vascular density in AMD treated for one year and healthy eyes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In our cross-sectional study OCT-A was performed on 60 eyes of 60 patients. Group AMD 20\u2009\u00d7\u2009consisted of patients receiving long-term (minimum 20 injections) aflibercept therapy (<jats:italic>n<\/jats:italic>\u2009=\u200917), and Group AMD one year consisted of patients treated for one year with a treat &amp; extend protocol (<jats:italic>n<\/jats:italic>\u2009=\u200925). The vascular density values obtained with OCT-A were compared with an age-matched control group of 18 healthy eyes. We examined the central retinal thickness (CRT), the vascular density of the fovea and parafovea in the superficial and deep retinal plexus, and evaluated the extent of the non-flow area and the foveal avascular zone (FAZ) on a 3\u2009\u00d7\u20093\u00a0mm macular region. Kruskal\u2013Wallis test was performed for statistical analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In Group AMD 20x, the vascular density of superficial retinal plexus in the fovea (<jats:italic>p<\/jats:italic>\u2009=\u20090.0022) and parafovea (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001) was significantly lower compared to Group one year and control group. In the deep retinal plexus, vascular density in the fovea (<jats:italic>p<\/jats:italic>\u2009=\u20090.0033) was significantly lower in both AMD groups compared to the control group, with no difference in the parafoveal region (<jats:italic>p<\/jats:italic>\u2009=\u20090.0774). The extent of non-flow area (<jats:italic>p<\/jats:italic>\u2009=\u20090.0003) and FAZ (<jats:italic>p<\/jats:italic>\u2009=\u20090.0008) were significantly larger in both AMD groups compared to the control group. There was a significant difference in CRT between those treated for one year and control eyes (<jats:italic>p<\/jats:italic>\u2009=\u20090.0036).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In our study, we demonstrated that macular vessel density was lower in the foveal area in the superficial retinal plexus in AMD patients after one year and long-term anti-VEGF treatment. These vascular density changes were absent in the parafoveal and whole areas of the deep retinal plexus. Our results indicate that long-term anti-VEGF treatment reduces the vascular density of the superficial retinal plexus to a greater extent compared to the deep retinal plexus.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-022-02700-8","type":"journal-article","created":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T11:03:09Z","timestamp":1670238189000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Atrophy of retinal vessels in neovascular age-related macular degeneration following long-term treatment with 20 intravitreal anti-VEGF injections"],"prefix":"10.1186","volume":"22","author":[{"given":"Mikl\u00f3s D.","family":"Resch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniko","family":"Balogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilmann","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n Z.","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia Cabrera","family":"DeBuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"issue":"9","key":"2700_CR1","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1136\/bjophthalmol-2014-305702","volume":"98","author":"U Schmidt-Erfurth","year":"2014","unstructured":"Schmidt-Erfurth U, Chong V, Loewenstein A, Larsen M, Souied E, Schlingemann R, et al. Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA). Br J Ophthalmol. 2014;98(9):1144\u201367.","journal-title":"Br J Ophthalmol"},{"issue":"12","key":"2700_CR2","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1038\/eye.2017.143","volume":"31","author":"A Lotery","year":"2017","unstructured":"Lotery A, Griner R, Ferreira A, Milnes F, Dugel P. Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set. Eye (Lond). 2017;31(12):1697\u2013706.","journal-title":"Eye (Lond)"},{"issue":"2","key":"2700_CR3","first-page":"Cd011346","volume":"2","author":"S Sarwar","year":"2016","unstructured":"Sarwar S, Clearfield E, Soliman MK, Sadiq MA, Baldwin AJ, Hanout M, et al. Aflibercept for neovascular age-related macular degeneration. The Cochrane database of systematic reviews. 2016;2(2):Cd011346.","journal-title":"The Cochrane database of systematic reviews"},{"key":"2700_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.758668","volume":"8","author":"A Arrigo","year":"2021","unstructured":"Arrigo A, Aragona E, Bordato A, Amato A, Borghesan F, Bandello F, et al. Morphological and Functional Relationship Between OCTA and FA\/ICGA Quantitative Features in AMD-Related Macular Neovascularization. Front Med. 2021;8: 758668.","journal-title":"Front Med"},{"key":"2700_CR5","doi-asserted-by":"crossref","unstructured":"Lupidi M, Schiavon S, Cerquaglia A, Fruttini D, Gujar R, Muzi A, et al. Real-world outcomes of anti-VEGF therapy in treatment-na\u00efve neovascular age-related macular degeneration diagnosed on OCT angiography: the REVEAL study. Acta ophthalmologica. 2021.","DOI":"10.1111\/aos.15005"},{"issue":"1","key":"2700_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40123-021-00443-1","volume":"11","author":"A Arrigo","year":"2022","unstructured":"Arrigo A, Amato A, Barresi C, Aragona E, Saladino A, Pina A, et al. Choroidal Modifications Preceding the Onset of Macular Neovascularization in Age-Related Macular Degeneration. Ophthalmol Therapy. 2022;11(1):377\u201386.","journal-title":"Ophthalmol Therapy"},{"issue":"11","key":"2700_CR7","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1097\/IAE.0000000000000836","volume":"35","author":"NW Muakkassa","year":"2015","unstructured":"Muakkassa NW, Chin AT, de Carlo T, Klein KA, Baumal CR, Witkin AJ, et al. CHARACTERIZING THE EFFECT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ON TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Retina (Philadelphia, Pa). 2015;35(11):2252\u20139.","journal-title":"Retina (Philadelphia, Pa)"},{"issue":"9","key":"2700_CR8","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1136\/bjophthalmol-2018-313065","volume":"103","author":"F Coscas","year":"2019","unstructured":"Coscas F, Lupidi M, Boulet JF, Sellam A, Cabral D, Serra R, et al. Optical coherence tomography angiography in exudative age-related macular degeneration: a predictive model for treatment decisions. Br J Ophthalmol. 2019;103(9):1342\u20136.","journal-title":"Br J Ophthalmol"},{"key":"2700_CR9","doi-asserted-by":"publisher","first-page":"8595278","DOI":"10.1155\/2018\/8595278","volume":"2018","author":"A Wyl\u0119ga\u0142a","year":"2018","unstructured":"Wyl\u0119ga\u0142a A, Wyl\u0119ga\u0142a F, Wyl\u0119ga\u0142a E. Aflibercept Treatment Leads to Vascular Abnormalization of the Choroidal Neovascularization. J Healthc Eng. 2018;2018:8595278.","journal-title":"J Healthc Eng"},{"key":"2700_CR10","doi-asserted-by":"crossref","unstructured":"Cennamo G, Montorio D, D\u2019Alessandro A, Napolitano P, D\u2019Andrea L, Tranfa F. Prospective Study of Vessel Density by Optical Coherence Tomography Angiography After Intravitreal Bevacizumab in Exudative Age-Related Macular Degeneration. Ophthalmol Therapy. 2020;9(1):77\u201385.","DOI":"10.1007\/s40123-019-00221-0"},{"key":"2700_CR11","doi-asserted-by":"crossref","unstructured":"Resch MD, Balogh A, Deak GG, Nagy ZZ, Papp A. Vascular density in age-related macular degeneration after one year of antiVEGF treatment with treat-and-extend and fixed regimens. PloS one. 2020;15(2).","DOI":"10.1371\/journal.pone.0229388"},{"issue":"5","key":"2700_CR12","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.oret.2017.09.002","volume":"2","author":"H Matsumoto","year":"2018","unstructured":"Matsumoto H, Morimoto M, Mimura K, Ito A, Akiyama H. Treat-and-Extend Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration: Efficacy and Macular Atrophy Development. Ophthalmology Retina. 2018;2(5):462\u20138.","journal-title":"Ophthalmology Retina"},{"key":"2700_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ajo.2019.09.004","volume":"209","author":"QS You","year":"2020","unstructured":"You QS, Wang J, Guo Y, Flaxel CJ, Hwang TS, Huang D, et al. Detection of Reduced Retinal Vessel Density in Eyes with Geographic Atrophy Secondary to Age-Related Macular Degeneration Using Projection-Resolved Optical Coherence Tomography Angiography. Am J Ophthalmol. 2020;209:206\u201312.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"2700_CR14","doi-asserted-by":"publisher","first-page":"e757","DOI":"10.1111\/aos.13157","volume":"94","author":"MR Munk","year":"2016","unstructured":"Munk MR, Ceklic L, Ebneter A, Huf W, Wolf S, Zinkernagel MS. Macular atrophy in patients with long-term anti-VEGF treatment for neovascular age-related macular degeneration. Acta Ophthalmol. 2016;94(8):e757\u201364.","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"2700_CR15","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3928\/23258160-20181203-02","volume":"49","author":"M Rispoli","year":"2018","unstructured":"Rispoli M, Savastano MC, Lumbroso B. Quantitative Vascular Density Changes in Choriocapillaris Around CNV After Anti-VEGF Treatment: Dark Halo. Ophthalmic Surg Lasers Imaging Retina. 2018;49(12):918\u201324.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"9","key":"2700_CR16","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.oret.2018.01.014","volume":"2","author":"SM McClintic","year":"2018","unstructured":"McClintic SM, Gao S, Wang J, Hagag A, Lauer AK, Flaxel CJ, et al. Quantitative Evaluation of Choroidal Neovascularization under Pro Re Nata Anti-Vascular Endothelial Growth Factor Therapy with OCT Angiography. Ophthalmology Retina. 2018;2(9):931\u201341.","journal-title":"Ophthalmology Retina"},{"key":"2700_CR17","doi-asserted-by":"publisher","first-page":"3751702","DOI":"10.1155\/2018\/3751702","volume":"2018","author":"A Miere","year":"2018","unstructured":"Miere A, Oubraham H, Amoroso F, Butori P, Astroz P, Semoun O, et al. Optical Coherence Tomography Angiography to Distinguish Changes of Choroidal Neovascularization after Anti-VEGF Therapy: Monthly Loading Dose versus Pro Re Nata Regimen. Journal of ophthalmology. 2018;2018:3751702.","journal-title":"Journal of ophthalmology"},{"key":"2700_CR18","doi-asserted-by":"crossref","unstructured":"Savastano MC, Rizzo C, Gambini G, Savastano A, Falsini B, Bacherini D, et al. Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections. Diagnostics (Basel, Switzerland). 2021;11(11).","DOI":"10.3390\/diagnostics11111958"},{"key":"2700_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40942-020-00242-z","volume":"6","author":"ES Levine","year":"2020","unstructured":"Levine ES, Custo Greig E, Mendon\u00e7a LSM, Gulati S, Despotovic IN, Alibhai AY, et al. The long-term effects of anti-vascular endothelial growth factor therapy on the optical coherence tomography angiographic appearance of neovascularization in age-related macular degeneration. International journal of retina and vitreous. 2020;6:39.","journal-title":"International journal of retina and vitreous"},{"issue":"1","key":"2700_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jcjo.2020.07.004","volume":"56","author":"R Mirshahi","year":"2021","unstructured":"Mirshahi R, Falavarjani KG, Molaei S, Habibi A, Anvari P, Khorasani MA, et al. Macular microvascular changes after intravitreal bevacizumab injection in diabetic macular edema. Can J Ophthalmol. 2021;56(1):57\u201365.","journal-title":"Can J Ophthalmol"},{"key":"2700_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2147\/OPTH.S285388","volume":"15","author":"S Dabir","year":"2021","unstructured":"Dabir S, Rajan M, Parasseril L, Bhatt V, Samant P, Webers CAB, et al. Early Visual Functional Outcomes and Morphological Responses to Anti-Vascular Growth Factor Therapy in Diabetic Macular Oedema Using Optical Coherence Tomography Angiography. Clin Ophthalmol. 2021;15:331\u20139.","journal-title":"Clin Ophthalmol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02700-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-022-02700-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02700-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T18:06:22Z","timestamp":1670522782000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-022-02700-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2700"],"URL":"https:\/\/doi.org\/10.1186\/s12886-022-02700-8","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"29 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was approved by the Regional and Institutional Committee of Science and Research Ethics s (Semmelweis University No 253\/2016). The study was conducted according to the tenets of the Declaration of Helsinki, and applicable national and local requirements. All patients signed written informed consent before entering the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable in the declarations section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"469"}}